Cellectric Biosciences

medical devices

About

Cellectric Biosciences is a seed-stage biotech startup focused on developing a proprietary platform for automated cell manipulation using electromagnetic technology. Their innovative approach utilizes electric fields to enhance precision medicine and improve diagnostic processes. The technology allows for selective and scalable processing of cell suspensions, enabling high selectivity in sample preparation through patented dielectric filter technology. Key applications of Cellectric's platform include cell isolation, molecular transport, cell sorting, and non-denaturing cell lysis. The company aims to accelerate sepsis diagnosis by enabling fast and automated detection of analytes in complex human samples, which can save lives and reduce healthcare costs. Founded in 2021 by Klemens Wassermann and Terje Wimberger, Cellectric has assembled a multidisciplinary team of about 20 experts. Their vision is to lead in electrodynamic applications for biotechnology and bioelectric medicine, empowering faster precision medicine through their advanced technology.

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Google Maps (Non Paid Users) Google Maps WordPress.org Nginx Mobile Friendly Google Tag Manager Circle

Keywords

electroporation invitro diagnostics sample preparation bioprocessing cell therapy cell isolation drug delivery decontamination viable pathogens electromagnetic sample prep healthcare technology biomedical innovation b2b cell lysis sepsis diagnosis electrome technology clinical samples research and development in the physical engineering and life sciences sample processing sample preparation platform diagnostics technology healthcare equipment & supplies electrodynamic cell manipulation services pathogen detection microbial detection biotechnology electric fields

Location

6 Giefinggasse, Vienna, Vienna, Austria, 1210

Related Companies

Companies in the same industry